Skip to content

Effect of meditation on hemodialysis adequacy and some psychological symptoms

Effect of meditation on hemodialysis adequacy and its psychological complications among patients undergoing hemodialysis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014102917454N3
Enrollment
67
Registered
2014-12-07
Start date
2014-11-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Anxiety. Condition 2: Depression. Condition 3: Stress. Anxiety disorder, unspecified Depressive episode, unspecified Stress, not elsewhere classified

Interventions

Intervention 1: The program comprises three 15- to 20-minutes educational practice sessions weekly offered over an eight-week period. Half an hour before starting dialysis, patients will attend in a r
Behavior
In order to decrease the investigator bias, the tutor and the researcher will attend the control group half an hour once a week and will discuss the dialysis and their related problems.
The program comprises three 15- to 20-minutes educational practice sessions weekly offered over an eight-week period. Half an hour before starting dialysis, patients will attend in a room located in t

Sponsors

Vice chancellor for research, Zanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The inclusion criteria: diagnosed with chronic kidney disease by their physicians; being under hemodialysis for at least three months; not having participated in other intervention studies; ability to participate in training sessions; ability to do meditation exercises; being registered in the hospital; lack of previous experiences with meditation; and lack of specific medical prohibitions, such as deafness, blindness, end-stage heart failure, brain trauma, uncontrolled hypertension and acute glaucoma; being consent to participate in the study; Lack of psychological drug use; lack of proved psychological disease. The exclusion criteria include unable or unwilling to participate in a group program; having reduced cognitive ability; hospitalized because of other medical conditions; having contraindications for doing meditation exercises; kidney transplantation during the study or referring to other hospitals; fistula or graft damages; and using psychological medications during the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Anxiety. Timepoint: Before the intervention, four weeks after the intervention and after 8 weeks of intervention. Method of measurement: Depression, Anxiety, Stress Scale- 21 (DASS-21).;Depression. Timepoint: Before the intervention, four weeks after the intervention and after 8 weeks of intervention. Method of measurement: Depression, Anxiety, Stress Scale- 21 (DASS-21).;Stress. Timepoint: Before the intervention, four weeks after the intervention and after 8 weeks of intervention. Method of measurement: Depression, Anxiety, Stress Scale- 21 (DASS-21).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKourosh Amini

Zanjan University of Medical Sciences

korosh@zums.ac.ir+98 24337751314

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026